CHRNA7 and ischemic cardiomyopathy: In a model of ischemic cardiomyopathy, Lin et al. [22] reported cardioprotective effects when rats received daily treatment with α7nAChR agonist PNU-292987 for four weeks, demonstrating an improved ejection fraction in rats receiving α7nAChR agonist PNU-292827.